跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,189 条关于
“Anti-CD38”
全部
20,189
临床试验
10,229
药物
3,976
机构
78
资讯
5,906
去年
CASI Pharmaceuticals Names David Cory CEO to Advance Anti-CD38 Antibody CID-103 Program
5个月前
Takeda's Anti-CD38 Therapy Mezagitamab Achieves 91% Response Rate in Immune Thrombocytopenia Phase II Trial
去年
XOMA Royalty Acquires $30 Million Mezagitamab Rights from BioInvent as Anti-CD38 Antibody Advances to Phase 3
去年
CASI Pharmaceuticals Initiates Phase 1/2 Trial of CID-103 for Immune Thrombocytopenia
4年前
Teclistamab-Daratumumab Combination Shows Promising Results in Heavily Pretreated Multiple Myeloma Patients
去年
European Commission Approves Sanofi's Sarclisa with VRd for Newly Diagnosed Multiple Myeloma
8年前
GSK's BCMA-Targeting ADC, GSK2857916, Receives FDA Breakthrough Therapy Designation for Multiple Myeloma
去年
Biogen's Felzartamab Shows Promising Results in IgA Nephropathy Phase 2 Trial
9个月前
CASI Pharmaceuticals' CID-103 Shows 73% Response Rate in Phase 1 Immune Thrombocytopenia Trial
去年
FDA Places Clinical Hold on CASI Pharmaceuticals' CID-103 Trial
第 1 页,共 591 页
上一页
下一页